Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
An important feature of the development of many human and animal tumours is the appearance of pre-malignant benign lesions, some of which undergo further changes during progression to malignancy. Many of the currently accepted concepts of multi-stage carcinogenesis have been developed using an experimental model based on the chemical induction of tumours in mouse skin. In this system, many of the premalignant papillomas which arise are promoter-dependent, and appear to regress if promoter treatment is interrupted, whereas others progress to form autonomous benign lesions and, in some cases, malignant carcinomas. Although the number and nature of the events leading to malignancy are not known, DNA transfection experiments have led to the identification of several genes which may be qualitatively altered in tumour cells (see ref. 6 for review). We have previously shown that DNA from transplantable mouse skin carcinomas induced by chemical carcinogens has the ability to transform NIH/3T3 cells, and that the gene responsible for the transformation is an activated form of the mouse cellular Harvey-ras gene (c-rasH). We have now investigated the stage of carcinogenesis at which the proto-oncogene acquires transforming activity. We demonstrate that primary papillomas induced by chemical carcinogens in two different mouse strains have an activated c-rasH gene. This constitutes the first report of a benign tumour which contains DNA with detectable transforming activity. In addition, steady-state levels of c-rasH gene transcripts are elevated in the papillomas as compared with normal epidermis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, these G4 TERCÀ/À APC min mice exhibited a profound suppression of more advanced adenomatous lesions in association with significant intratumoral growth arrest and apoptosis (89).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [89]
In the citing paper
“Quantitative analysis of mice with multiple intestinal neoplasia (min) provided further evidence that telomere shortening can dramatically impair tumor development in epithelial cells at specific stages in the malignant transformation process.”
From Telomeres and telomerase in cancer (2010) · cites this paper as [89]
In the citing paper
“In this APC min model, the addition of telomere dysfunction resulted in an increase in early neoplastic lesions probably due to chromosome instability resulting in increased loss of the remaining wild-type APC allele.”
From Telomeres and telomerase in cancer (2010) · cites this paper as [89]
In the citing paper
“The antitumor effects of telomere dysfunction resulted in dramatically increased survival in G4 TERCÀ/À APC min mice by preventing blood loss caused by gastrointestinal tract adenomas.”
From Telomeres and telomerase in cancer (2010) · cites this paper as [89]
In the citing paper
“Anaphase bridges, a hallmark of dysfunctional telomeres, are low in adenomas but increase substantially at the adenoma-carcinoma transition.Anaphase bridges become significantly more abundant at the pre-invasive and invasive colon cancer stages (89).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [89]
Citations
Cites
Mechanism of activation of a human oncogene
Tabin, C. J., Bradley, S. M., Bargmann, C. I., Weinberg, R. A., Papageorge, A. G., Scolnick, E. M., Dhar, R., Lowy, D. R., & Chang, E. H. (1982) · Nature · doi:10.1038/300143a0 · Cited by 1,393
Reddy, E. P., Reynolds, R. K., Santos, E., & Barbacid, M. (1982) · Nature · doi:10.1038/300149a0 · Cited by 1,391
Mutation and Cancer: A Model for Human Carcinogenesis2
Moolgavkar, S. H., & Knudson, A. G. (1981) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/66.6.1037 · Cited by 1,086
Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene
Parada, L. F., Tabin, C. J., Shih, C., & Weinberg, R. A. (1982) · Nature · doi:10.1038/297474a0 · Cited by 944
Der, C. J., Krontiris, T. G., & Cooper, G. M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.11.3637 · Cited by 800
The Function and Mechanism of Promoters of Carcinogenesis
Boutwell, R. K., & Sivak, A. (1973) · CRC Critical Reviews in Toxicology · doi:10.3109/10408447309025704 · Cited by 746
Santos, E., Tronick, S. R., Aaronson, S. A., Pulciani, S., & Barbacid, M. (1982) · Nature · doi:10.1038/298343a0 · Cited by 623
Cooper, G. M. (1982) · Science · doi:10.1126/science.6285471 · Cited by 606
A Two-stage Theory of Carcinogenesis in Relation to the Age Distribution of Human Cancer
Armitage, P., & Doll, R. (1957) · British Journal of Cancer · doi:10.1038/bjc.1957.22 · Cited by 555
Oncogenes in solid human tumours
Pulciani, S., Santos, E., Lauver, A. V., Long, L. K., Aaronson, S. A., & Barbacid, M. (1982) · Nature · doi:10.1038/300539a0 · Cited by 478
Balmain, A., & Pragnell, I. B. (1983) · Nature · doi:10.1038/303072a0 · Cited by 423
Self-citationDual evolutionary origin for the rat genetic sequences of Harvey murine sarcoma virus
Ellis, R. W., DeFeo, D., Maryak, J. M., Young, H. A., Shih, T. Y., Chang, E. H., Lowy, D. R., & Scolnick, E. M. (1980) · Journal of Virology · doi:10.1128/jvi.36.2.408-420.1980 · Cited by 370
Shimizu, K., Goldfarb, M., Perucho, M., & Wigler, M. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.2.383 · Cited by 286
A mathematical model for the age distribution of cancer in man
Cook, P. J., Doll, R., & Fellingham, S. A. (1969) · International Journal of Cancer · doi:10.1002/ijc.2910040113 · Cited by 282
Cloning and characterisation of the abundant cytoplasmic 7S RNA from mouse cells
Balmain, A., Krumlauf, R. K., Vass, J. K., & Birnie, G. D. (1982) · Nucleic Acids Research · doi:10.1093/nar/10.14.4259 · Cited by 148
Self-citationDiGiovanni, J., Slaga, T. J., & Boutwell, R. K. (1980) · Carcinogenesis · doi:10.1093/carcin/1.5.381 · Cited by 105
Hennings, H., Devor, D. E., Wenk, M. L., Slaga, T. J., Former, B. F., Colburn, N. H., Bowden, G. T., Elgjo, K., & Yuspa, S. H. (1981) · PubMed · Cited by 97
Self-citationAlfred, G. K. (1983) · Cancer Investigation · doi:10.3109/07357908309042421 · Cited by 40
Knudson, A. G. (1983) · Cancer Investigation · doi:10.3109/07357908309042420 · Cited by 17
Research works printed but not linked: 4
- Pierce, G. B. & Fennell, R. H. in Cancer Medicine (eds Holland, J. F. & Frei, E.) 149–167 (Lea & Febiger, Philadelphia, 1982).
- Hecker, E., Fusenig, N. E., Kunz, W., Marks, F. & Thielmann, H. W. (eds) Carcinogenesis Vol. 7 (Raven, New York, 1982).
- Burns, F. J., Vanderlaan, M., Snyder, E. & Albert, R. E. Carcinogenesis Vol. 2 (eds Slaga, T. J., Sivak, A. & Boutwell, R. K.) 91–96 (Raven, New York, 1978).
- Hennings, H. et al. Cancer Res. 41, 773–779 (1981).
Cited by
RAS oncogenes: the first 30 years
Malumbres, M., & Barbacid, M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1097 · Cited by 1,902
RAS oncogenes: weaving a tumorigenic web
Pylayeva-Gupta, Y., Grabocka, E., & Bar-Sagi, D. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3106 · Cited by 1,789
The Molecular Genetics of Cancer
Bishop, J. M. (1987) · Science · doi:10.1126/science.3541204 · Cited by 1,688
Ras oncogenes: split personalities
Karnoub, A. E., & Weinberg, R. A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2438 · Cited by 1,467
“For example, mouse mammary and skin tumours that were induced by the topical application of carcinogens contained H- Ras mutation”
RAS Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors
Su, F., Viros, A., Milagre, C., Trunzer, K., Bollag, G., Spleiss, O., Reis-Filho, J. S., Kong, X., Koya, R. C., Flaherty, K. T., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1105358 · Cited by 1,038
Metadata
- Authors
- Balmain, A., Ramsden, M., Bowden, G. T., & Smith, J.
- Affiliations
- Cancer Research UK Scotland Institute (GB)
- ORCID
- Balmain, Allan
- Venue
- Nature
- Published
- 1984-02
- Volume
- 307
- Issue
- 5952
- Pages
- 658-660
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2015936619
- Cited by
- 529
- References
- 19
- Citations by year
- 2026: 1 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 4 · 2019: 4 · 2018: 6 · 2017: 4 · 2016: 5 · 2015: 16 · 2014: 5 · 2013: 9 · 2012: 9
- FWCI
- 19.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Carcinogens and Genotoxicity Assessment
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Keywords
- skin papilloma, chemical carcinogenesis, precancerous lesions, proto-oncogene activation, transforming activity, gene expression, epidermis
- MeSH terms
- Proto-Oncogene Mas, Animals, Cell Transformation, Neoplastic, Gene Expression Regulation, Oncogenes, Papilloma, Skin Neoplasms, Transcription, Genetic, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.